However, even with this short-term aggressive melanoma model, SAM delayed tumor growth, and the combination of SAM with anti-PD-1 had a superior protective effect and restored CD8+ T cell proliferation and effector functions within the tumor microenvironment. Here, PDCD1 is linked to neoplasm.